Abstract
To identify genes and signaling pathways that initiate Neurofibromatosis type 1 (NF1) neurofibromas, we used unbiased insertional mutagenesis screening, mouse models, and molecular analyses. We mapped an Nf1-Stat3-Arid1b/β-catenin pathway that becomes active in the context of Nf1 loss. Genetic deletion of Stat3 in Schwann cell progenitors (SCPs) and Schwann cells (SCs) prevents neurofibroma formation, decreasing SCP self-renewal and β-catenin activity. β-catenin expression rescues effects of Stat3 loss in SCPs. Importantly, P-STAT3 and β-catenin expression correlate in human neurofibromas. Mechanistically, P-Stat3 represses Gsk3β and the SWI/SNF gene Arid1b to increase β-catenin. Knockdown of Arid1b or Gsk3β in Stat3(fl/fl);Nf1(fl/fl);DhhCre SCPs rescues neurofibroma formation after in vivo transplantation. Stat3 represses Arid1b through histone modification in a Brg1-dependent manner, indicating that epigenetic modification plays a role in early tumorigenesis. Our data map a neural tumorigenesis pathway and support testing JAK/STAT and Wnt/β-catenin pathway inhibitors in neurofibroma therapeutic trials.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
Carcinogenesis / genetics*
-
Carcinogenesis / metabolism
-
Carcinogenesis / pathology
-
DNA Helicases / genetics
-
DNA Helicases / metabolism
-
DNA-Binding Proteins / antagonists & inhibitors
-
DNA-Binding Proteins / genetics*
-
DNA-Binding Proteins / metabolism
-
Disease Models, Animal
-
Female
-
Gene Expression Regulation, Neoplastic*
-
Glycogen Synthase Kinase 3 beta / antagonists & inhibitors
-
Glycogen Synthase Kinase 3 beta / genetics
-
Glycogen Synthase Kinase 3 beta / metabolism
-
Histones / genetics
-
Histones / metabolism
-
Humans
-
Mice
-
Mice, Nude
-
Mutagenesis, Insertional
-
N-Terminal Acetyltransferase A / antagonists & inhibitors
-
N-Terminal Acetyltransferase A / genetics*
-
N-Terminal Acetyltransferase A / metabolism
-
Neoplasm Transplantation
-
Neural Stem Cells / metabolism
-
Neural Stem Cells / pathology
-
Neurofibromatosis 1 / genetics*
-
Neurofibromatosis 1 / metabolism
-
Neurofibromatosis 1 / pathology
-
Neurofibromin 1 / genetics
-
Neurofibromin 1 / metabolism
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism
-
Peripheral Nervous System Neoplasms / genetics*
-
Peripheral Nervous System Neoplasms / metabolism
-
Peripheral Nervous System Neoplasms / pathology
-
Phosphorylation
-
RNA, Small Interfering / genetics
-
RNA, Small Interfering / metabolism
-
STAT3 Transcription Factor / antagonists & inhibitors
-
STAT3 Transcription Factor / genetics*
-
STAT3 Transcription Factor / metabolism
-
Schwann Cells / metabolism
-
Schwann Cells / pathology
-
Signal Transduction
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
-
beta Catenin / genetics*
-
beta Catenin / metabolism
Substances
-
CTNNB1 protein, mouse
-
DNA-Binding Proteins
-
Histones
-
Neurofibromin 1
-
Nuclear Proteins
-
RNA, Small Interfering
-
STAT3 Transcription Factor
-
Stat3 protein, mouse
-
Transcription Factors
-
beta Catenin
-
N-Terminal Acetyltransferase A
-
Naa11 protein, mouse
-
Glycogen Synthase Kinase 3 beta
-
Smarca4 protein, mouse
-
DNA Helicases